Castaldo, Vittorio
Minopoli, Michele
Di Modugno, Francesca
Sacconi, Andrea
Liguoro, Domenico
Frigerio, Rachele
Ortolano, Arianna
Di Martile, Marta
Gesualdi, Luisa
Madonna, Gabriele
Capone, Mariaelena
Cirombella, Roberto
Catizone, Angiolina
Del Bufalo, Donatella
Vecchione, Andrea
Carriero, Maria Vincenza
Ascierto, Paolo Antonio
Mancini, Rita
Fattore, Luigi http://orcid.org/0000-0002-9245-0126
Ciliberto, Gennaro
Funding for this research was provided by:
Associazione Italiana per la Ricerca sul Cancro (IG19865, IG24451)
Lazio Innova (85-2017-13750, A0375-2020-36657)
Ministero dell’Istruzione, dell’Università e della Ricerca (2017HWTP2K, 2017HWTP2K, PNRR M4C2-Investimento 1.4- CN00000041”)
Ministero della Salute (L2/1, PNRR-POC-2022-12375713)
Lega italiana per la lotta contro i tumori (2021U0001637)
Article History
Received: 21 August 2023
Accepted: 29 October 2023
First Online: 27 November 2023
Declarations
:
: The use of human samples was approved by Istituto Pascale’s Ethical Committee with the protocol DSC/2893 on April 11, 2015. All patients signed a general informed consent, which allowed the use of this material for research purposes in an anonymous manner.
: Not applicable.
: All the authors declare no competing interests with the exception of P.A.A. He has/had a consultant/advisory role for Bristol Myers Squibb, Roche-Genentech, Merck Sharp & Dohme, Novartis, Merck Serono, Pierre-Fabre, AstraZeneca, Sun Pharma, Sanofi, Idera, Sandoz, Immunocore, 4SC, Italfarmaco, Nektar, Boehringer-Ingelheim, Eisai, Regeneron, DaiichiSankyo, Pfizer, Oncosec, Nouscom, Lunaphore, Seagen, iTeos, Medicenna, Bio-Al Health, ValoTX, Replimmune. He also received research funding from Bristol Myers Squibb, Roche-Genentech, Pfizer, Sanofi. Travel support by Pfizer. The funders of this study had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.